Download PDF
Neuropediatrics 2023; 54(06): 422-425
DOI: 10.1055/a-2003-9886
Short Communication

Infantile Spasms without Hypsarrhythmia and Paroxysmal Eye–Head Movements in an Infant with a Pyridoxine-Dependent Epilepsy due to PLPBP/PLPHP Deficiency

Judith Kalser
1   Pediatric Neurology and Neurorehabilitation Unit, Department of Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland
,
Fabienne Giuliano
2   Division of Genetic Medicine, Department of Medicine, Lausanne University Hospital, Lausanne, Switzerland
,
Maria Peralta
3   Pediatric Unit for Metabolic Diseases, Department of Woman-Mother-Child, Lausanne University Hospital, Lausanne, Switzerland
,
Barbara Plecko
4   Division of General Pediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria
,
Bigna K. Bölsterli 
5   Child Development Center, University Children's Hospital Zurich, Zurich, Switzerland
6   Department of Pediatric Neurology, University Children's Hospital Zurich, Zurich, Switzerland
7   Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland
8   Department of Pediatric Neurology, Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland
› Author Affiliations Funding B.K.B. was supported by the “Children's Research Center (CRC) protected time 2020–program.”
› Further Information
Also available at
    Permissions and Reprints

Abstract

To describe a new phenotype and the diagnostic workup of a vitamin-B6-dependent epilepsy due to pyridoxal 5′-phosphate-binding protein (PLPBP) deficiency in an infant with early-onset epilepsy at the age of 5 years 6 months. Following immediate and impressive clinical response to treatment with pyridoxine, metabolic screening for vitamin-B6-dependent epilepsies and targeted next-generation sequencing (NGS)-based gene panel analysis were performed. Potentially pathogenic variants were confirmed by Sanger sequencing in the patient, and variants were analyzed in both parents to confirm biallelic inheritance. The clinical phenotype and course of disease were compared to the 44 cases reported in the literature, harboring variants in pyridoxal phosphate homeostasis protein (PLPHP) and with cases of vitamin-B6-dependent epilepsy due to other known causative genes. Levels of alpha-aminoadipic semialdehyde in urine and amino acids were normal. Two inherited pathogenic variations in PLPHP were found in compound heterozygosity, including one novel deletion. We here describe a previously unreported individual harboring biallelic pathogenic PLPHP variants presenting with paroxysmal eye–head movements followed by epileptic spasms and an almost normal interictal electroencephalogram, thus expanding the clinical spectrum of PLPBP deficiency. This warrants consideration of vitamin-B6-dependent epilepsies in patients with early-onset epilepsy, including epileptic spasms, and eye movement disorders also beyond the neonatal period even when metabolic screening for vitamin-B6-dependent epilepsies is negative. PLPHP should be included systematically in NGS epilepsy gene panels.

Keywords

pyridoxine - vitamin B6 - paroxysmal movement disorder - epilepsy - West's syndrome - PROSC


Publication History

Received: 26 September 2022

Accepted: 21 December 2022

Accepted Manuscript online:
28 December 2022

Article published online:
24 February 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ahmed S, DeBerardinis RJ, Ni M, Afroze B. Vitamin B6-dependent epilepsy due to pyridoxal phosphate-binding protein (PLPBP) defect - first case report from Pakistan and review of literature. Ann Med Surg (Lond) 2020; 60: 721-727
    CrossrefPubMedGoogle Scholar
  • 2 Johannsen J, Bierhals T, Deindl P. et al. Excessive seizure clusters in an otherwise well-controlled epilepsy as a possible hallmark of untreated vitamin B6-responsive epilepsy due to a homozygous PLPBP missense variant. J Pediatr Genet 2019; 8 (04) 222-225
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Pal M, Lace B, Labrie Y. et al. A founder mutation in the PLPBP gene in families from Saguenay-Lac-St-Jean region affected by a pyridoxine-dependent epilepsy. JIMD Rep 2021; 59 (01) 32-41
    CrossrefPubMedGoogle Scholar
  • 4 Heath O, Pitt J, Mandelstam S, Kuschel C, Vasudevan A, Donoghue S. Early-onset vitamin B6-dependent epilepsy due to pathogenic PLPBP variants in a premature infant: a case report and review of the literature. JIMD Rep 2020; 58 (01) 3-11
    CrossrefPubMedGoogle Scholar
  • 5 Wilson MP, Plecko B, Mills PB, Clayton PT. Disorders affecting vitamin B6 metabolism. J Inherit Metab Dis 2019; 42 (04) 629-646
    CrossrefPubMedGoogle Scholar
  • 6 Caraballo RH, Ruggieri V, Gonzalez G. et al. Infantile spams without hypsarrhythmia: a study of 16 cases. Seizure 2011; 20 (03) 197-202
    CrossrefPubMedGoogle Scholar
  • 7 Marchi LR, Seraphim EA, Corso JT. et al. Epileptic spasms without hypsarrhythmia in infancy and childhood: tonic spasms as a seizure type. Epileptic Disord 2015; 17 (02) 188-193
    CrossrefPubMedGoogle Scholar
  • 8 Jiao X, Gong P, Niu Y, Zhang Y, Yang Z. A rare presentation characterized by epileptic spasms in ALDH7A1, pyridox(am)ine-5′-phosphate oxidase, and PLPBP deficiency. Front Genet 2022; 13: 804461
    CrossrefPubMedGoogle Scholar
  • 9 Gibaud M, Barth M, Lefranc J. et al. West syndrome is an exceptional presentation of pyridoxine- and pyridoxal phosphate-dependent epilepsy: data from a French cohort and review of the literature. Front Pediatr 2021; 9: 621200
    CrossrefPubMedGoogle Scholar
  • 10 Prunetti L, El Yacoubi B, Schiavon CR. et al. Evidence that COG0325 proteins are involved in PLP homeostasis. Microbiology (Reading) 2016; 162 (04) 694-706
    CrossrefPubMedGoogle Scholar
  • 11 Johnstone DL, Al-Shekaili HH, Tarailo-Graovac M. et al; Care4Rare Canada Consortium. PLPHP deficiency: clinical, genetic, biochemical, and mechanistic insights. Brain 2019; 142 (03) 542-559
    CrossrefPubMedGoogle Scholar
  • 12 Fung CW, Kwong AKY, Wong VCN. Gene panel analysis for nonsyndromic cryptogenic neonatal/infantile epileptic encephalopathy. Epilepsia Open 2017; 2 (02) 236-243
    CrossrefPubMedGoogle Scholar
  • 13 Mills PB, Camuzeaux SSM, Footitt EJ. et al. Epilepsy due to PNPO mutations: genotype, environment and treatment affect presentation and outcome. Brain 2014; 137 (Pt 5): 1350-1360
    CrossrefPubMedGoogle Scholar
  • 14 Koul R, Alfutaisi A, Abdelrahim R, Altihilli K. Pyridoxine responsive seizures: beyond aldehyde dehydrogenase 7a1. J Neurosci Rural Pract 2019; 10 (04) 613-616
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Pearson TS, Pons R, Engelstad K, Kane SA, Goldberg ME, De Vivo DC. Paroxysmal eye-head movements in Glut1 deficiency syndrome. Neurology 2017; 88 (17) 1666-1673
    CrossrefPubMedGoogle Scholar